Bionano Genomics (BNGO) Twitter Mentions Statistics 2025

181 21.6%

1W 40.3% 1M 56.7% 3M 17.7%

Est. daily mentions on Twitter.

Similar companies

Company		Twitter Mentions
	Amgen AMGN	74 39.6%
	Gilead Sciences GILD	85 9.6%
	Catalyst Pharmaceuticals CPRX	8 27.3%
	Inovio Pharmaceuticals INO	184 5.7%
	Anavex Life Sciences AVXL	27 44.9%

Month over Month

Est. daily mentions on Twitter.

Apr 2025	843	150.2%
Mar 2025	337	31.8%
Feb 2025	494

How often is Bionano Genomics mentioned on Twitter?

Bionano Genomics was mentioned an estimated 181 times in various tweets yesterday. In the last 30 days, Bionano Genomics has been mentioned around 451 times per day.

Analyzing Twitter Mentions, how is Bionano Genomics performing compared to its industry peers?

Bionano Genomics underperforms its industry peers when it comes to Twitter Mentions, ranking in the 15th percentile.

Why is it important to track Twitter mentions for Bionano Genomics?

By monitoring Twitter mentions for Bionano Genomics, investors gain real-time insights into public sentiment towards the company, its products, and its industry. Positive mentions may indicate growing interest, customer satisfaction, or emerging trends, while negative mentions can alert investors to potential issues, controversies, or market challenges. By tracking these mentions over time, investors can identify patterns, spot emerging trends, and make informed decisions based on the evolving sentiment and public perception of Bionano Genomics, ultimately improving their investment strategies.

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.